{"transactions":[{"id":4391104,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":177933,"kind":"person","name":"Moore Terrence O","position":1,"cik":"0001454276","reported_name":"Moore Terrence O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2017-03-11T01:37:19.000Z","date":"2017-03-08","kind":"grant","acquired":true,"shares":33750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option vest and become exercisable on March 8, 2018. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments."}],"balance_after":33750,"derivative":{"exercise_price":36.54,"expiration_date":"2027-03-07","underlying":"Common Stock","underlying_shares":33750},"source":{"system":"sec-edgar","filing":"0001415889-17-000407","document":"form4-03102017_050310.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917000407/form4-03102017_050310.xml","form_type":"4"}},{"id":4428349,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":177933,"kind":"person","name":"Moore Terrence O","position":1,"cik":"0001454276","reported_name":"Moore Terrence O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2017-02-23T23:01:24.000Z","date":"2017-02-21","kind":"exercise","acquired":false,"shares":7856,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the Stock Option vested and became exercisable on March 20, 2016. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments."}],"balance_after":82500,"derivative":{"exercise_price":34.45,"expiration_date":"2025-03-19","underlying":"Common Stock","underlying_shares":7856},"source":{"system":"sec-edgar","filing":"0001415889-17-000308","document":"form4-02232017_030207.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917000308/form4-02232017_030207.xml","form_type":"4"}},{"id":4428348,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":177933,"kind":"person","name":"Moore Terrence O","position":1,"cik":"0001454276","reported_name":"Moore Terrence O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2017-02-23T23:01:24.000Z","date":"2017-02-21","kind":"sale","acquired":false,"shares":7856,"price":39.65,"value":311490.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in September 2015, as amended in June 2016.  All sales under the trading plan have been completed."}],"balance_after":1671,"source":{"system":"sec-edgar","filing":"0001415889-17-000308","document":"form4-02232017_030207.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917000308/form4-02232017_030207.xml","form_type":"4"}},{"id":4428347,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":177933,"kind":"person","name":"Moore Terrence O","position":1,"cik":"0001454276","reported_name":"Moore Terrence O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2017-02-23T23:01:24.000Z","date":"2017-02-21","kind":"exercise","acquired":true,"shares":7856,"price":34.45,"value":270639.2,"ownership":{"direct":true},"balance_after":9527,"source":{"system":"sec-edgar","filing":"0001415889-17-000308","document":"form4-02232017_030207.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917000308/form4-02232017_030207.xml","form_type":"4"}},{"id":4443368,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":177933,"kind":"person","name":"Moore Terrence O","position":1,"cik":"0001454276","reported_name":"Moore Terrence O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2017-02-17T00:06:35.000Z","date":"2017-02-16","kind":"exercise","acquired":false,"shares":29644,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"25% of the shares subject to the Stock Option vested and became exercisable on March 20, 2016. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments."}],"balance_after":90356,"derivative":{"exercise_price":34.35,"expiration_date":"2025-03-19","underlying":"Common Stock","underlying_shares":29644},"source":{"system":"sec-edgar","filing":"0001415889-17-000282","document":"form4-02162017_040225.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917000282/form4-02162017_040225.xml","form_type":"4"}},{"id":4443367,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":177933,"kind":"person","name":"Moore Terrence O","position":1,"cik":"0001454276","reported_name":"Moore Terrence O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2017-02-17T00:06:35.000Z","date":"2017-02-16","kind":"exercise","acquired":false,"shares":19687,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"25% of the shares subject to the Stock Option vested and became exercisable on March 7, 2015. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments."}],"balance_after":13125,"derivative":{"exercise_price":27.2,"expiration_date":"2024-03-06","underlying":"Common Stock","underlying_shares":19687},"source":{"system":"sec-edgar","filing":"0001415889-17-000282","document":"form4-02162017_040225.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917000282/form4-02162017_040225.xml","form_type":"4"}},{"id":4443366,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":177933,"kind":"person","name":"Moore Terrence O","position":1,"cik":"0001454276","reported_name":"Moore Terrence O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2017-02-17T00:06:35.000Z","date":"2017-02-16","kind":"exercise","acquired":false,"shares":17421,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares subject to the Stock Option vested and became exercisable on August 19, 2014. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments."}],"balance_after":36102,"derivative":{"exercise_price":19.61,"expiration_date":"2023-08-18","underlying":"Common Stock","underlying_shares":17421},"source":{"system":"sec-edgar","filing":"0001415889-17-000282","document":"form4-02162017_040225.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917000282/form4-02162017_040225.xml","form_type":"4"}},{"id":4443365,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":177933,"kind":"person","name":"Moore Terrence O","position":1,"cik":"0001454276","reported_name":"Moore Terrence O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2017-02-17T00:06:35.000Z","date":"2017-02-15","kind":"exercise","acquired":false,"shares":1700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares subject to the Stock Option vested and became exercisable on August 19, 2014. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments."}],"balance_after":53523,"derivative":{"exercise_price":19.61,"expiration_date":"2023-08-18","underlying":"Common Stock","underlying_shares":1700},"source":{"system":"sec-edgar","filing":"0001415889-17-000282","document":"form4-02162017_040225.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917000282/form4-02162017_040225.xml","form_type":"4"}},{"id":4443364,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":177933,"kind":"person","name":"Moore Terrence O","position":1,"cik":"0001454276","reported_name":"Moore Terrence O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2017-02-17T00:06:35.000Z","date":"2017-02-14","kind":"exercise","acquired":false,"shares":74381,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares subject to the Stock Option vested and became exercisable on August 19, 2014. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments."}],"balance_after":55223,"derivative":{"exercise_price":19.61,"expiration_date":"2023-08-18","underlying":"Common Stock","underlying_shares":74381},"source":{"system":"sec-edgar","filing":"0001415889-17-000282","document":"form4-02162017_040225.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917000282/form4-02162017_040225.xml","form_type":"4"}},{"id":4443363,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":177933,"kind":"person","name":"Moore Terrence O","position":1,"cik":"0001454276","reported_name":"Moore Terrence O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2017-02-17T00:06:35.000Z","date":"2017-02-14","kind":"exercise","acquired":false,"shares":12747,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares subject to the Stock Option vested and became exercisable on August 19, 2014. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments."}],"balance_after":7649,"derivative":{"exercise_price":19.61,"expiration_date":"2023-08-18","underlying":"Common Stock","underlying_shares":12747},"source":{"system":"sec-edgar","filing":"0001415889-17-000282","document":"form4-02162017_040225.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917000282/form4-02162017_040225.xml","form_type":"4"}},{"id":4443362,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":177933,"kind":"person","name":"Moore Terrence O","position":1,"cik":"0001454276","reported_name":"Moore Terrence O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2017-02-17T00:06:35.000Z","date":"2017-02-16","kind":"sale","acquired":false,"shares":66752,"price":39.8807,"value":2662116.4864,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in September 2015, as amended in June 2016."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $39.65 to $40.38 per share, inclusive.The reporting person undertakes to provide ACADIA Pharmaceuticals Inc., any security holder of ACADIA Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range."}],"balance_after":1671,"source":{"system":"sec-edgar","filing":"0001415889-17-000282","document":"form4-02162017_040225.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917000282/form4-02162017_040225.xml","form_type":"4"}},{"id":4443361,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":177933,"kind":"person","name":"Moore Terrence O","position":1,"cik":"0001454276","reported_name":"Moore Terrence O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2017-02-17T00:06:35.000Z","date":"2017-02-16","kind":"exercise","acquired":true,"shares":29644,"price":34.45,"value":1021235.8,"ownership":{"direct":true},"balance_after":68423,"source":{"system":"sec-edgar","filing":"0001415889-17-000282","document":"form4-02162017_040225.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917000282/form4-02162017_040225.xml","form_type":"4"}},{"id":4443360,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":177933,"kind":"person","name":"Moore Terrence O","position":1,"cik":"0001454276","reported_name":"Moore Terrence O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2017-02-17T00:06:35.000Z","date":"2017-02-16","kind":"exercise","acquired":true,"shares":19687,"price":27.2,"value":535486.4,"ownership":{"direct":true},"balance_after":38779,"source":{"system":"sec-edgar","filing":"0001415889-17-000282","document":"form4-02162017_040225.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917000282/form4-02162017_040225.xml","form_type":"4"}},{"id":4443359,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":177933,"kind":"person","name":"Moore Terrence O","position":1,"cik":"0001454276","reported_name":"Moore Terrence O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2017-02-17T00:06:35.000Z","date":"2017-02-16","kind":"exercise","acquired":true,"shares":17421,"price":19.61,"value":341625.81,"ownership":{"direct":true},"balance_after":19092,"source":{"system":"sec-edgar","filing":"0001415889-17-000282","document":"form4-02162017_040225.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917000282/form4-02162017_040225.xml","form_type":"4"}},{"id":4443358,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":177933,"kind":"person","name":"Moore Terrence O","position":1,"cik":"0001454276","reported_name":"Moore Terrence O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2017-02-17T00:06:35.000Z","date":"2017-02-15","kind":"sale","acquired":false,"shares":1700,"price":39.65,"value":67405.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in September 2015, as amended in June 2016."}],"balance_after":1671,"source":{"system":"sec-edgar","filing":"0001415889-17-000282","document":"form4-02162017_040225.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917000282/form4-02162017_040225.xml","form_type":"4"}},{"id":4443357,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":177933,"kind":"person","name":"Moore Terrence O","position":1,"cik":"0001454276","reported_name":"Moore Terrence O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2017-02-17T00:06:35.000Z","date":"2017-02-15","kind":"exercise","acquired":true,"shares":1700,"price":19.61,"value":33337.0,"ownership":{"direct":true},"balance_after":3371,"source":{"system":"sec-edgar","filing":"0001415889-17-000282","document":"form4-02162017_040225.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917000282/form4-02162017_040225.xml","form_type":"4"}},{"id":4443356,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":177933,"kind":"person","name":"Moore Terrence O","position":1,"cik":"0001454276","reported_name":"Moore Terrence O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2017-02-17T00:06:35.000Z","date":"2017-02-14","kind":"sale","acquired":false,"shares":89088,"price":39.6863,"value":3535573.0944,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in September 2015, as amended in June 2016."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $39.65 to $39.72 per share, inclusive.The reporting person undertakes to provide ACADIA Pharmaceuticals Inc., any security holder of ACADIA Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range."}],"balance_after":1671,"source":{"system":"sec-edgar","filing":"0001415889-17-000282","document":"form4-02162017_040225.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917000282/form4-02162017_040225.xml","form_type":"4"}},{"id":4443355,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":177933,"kind":"person","name":"Moore Terrence O","position":1,"cik":"0001454276","reported_name":"Moore Terrence O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2017-02-17T00:06:35.000Z","date":"2017-02-14","kind":"exercise","acquired":true,"shares":87128,"price":19.61,"value":1708580.08,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 717, 1,243, 461 and 1,210 shares acquired in November 2014, May 2015, November 2015 and May 2016, respectively, by Mr. Moore under the ACADIA Pharmaceuticals Employee Stock Purchase Plan, as amended."}],"balance_after":90759,"source":{"system":"sec-edgar","filing":"0001415889-17-000282","document":"form4-02162017_040225.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917000282/form4-02162017_040225.xml","form_type":"4"}}]}